429 related articles for article (PubMed ID: 32732010)
1. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.
Hamadeh A; Aldujeli A; Briedis K; Tecson KM; Sanz-Sánchez J; Al Dujeili M; Al-Obeidi A; Diez JL; Žaliūnas R; Stoler RC; McCullough PA
Am J Cardiol; 2020 Sep; 131():1-6. PubMed ID: 32732010
[TBL] [Abstract][Full Text] [Related]
2. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
Choudry FA; Hamshere SM; Rathod KS; Akhtar MM; Archbold RA; Guttmann OP; Woldman S; Jain AK; Knight CJ; Baumbach A; Mathur A; Jones DA
J Am Coll Cardiol; 2020 Sep; 76(10):1168-1176. PubMed ID: 32679155
[TBL] [Abstract][Full Text] [Related]
3. ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.
Gramegna M; Baldetti L; Beneduce A; Pannone L; Falasconi G; Calvo F; Pazzanese V; Sacchi S; Pagnesi M; Moroni F; Ajello S; Melisurgo G; Agricola E; Camici PG; Scandroglio AM; Landoni G; Ciceri F; Zangrillo A; Cappelletti AM
Circ Cardiovasc Interv; 2020 Aug; 13(8):e009413. PubMed ID: 32791953
[TBL] [Abstract][Full Text] [Related]
4. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Sudhakar D; Jneid H; Lakkis N; Kayani WT
Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
[No Abstract] [Full Text] [Related]
5. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19.
Setia G; Tyler J; Kwan A; Faguet J; Sharma S; Singh S; Azarbal B; Tompkins R; Chinchilla D; Ghandehari S
Rev Cardiovasc Med; 2020 Jun; 21(2):289-295. PubMed ID: 32706216
[TBL] [Abstract][Full Text] [Related]
6. Who Has Seen Patients With ST-Segment-Elevation Myocardial Infarction? First Results From Italian Real-World Coronavirus Disease 2019.
Cammalleri V; Muscoli S; Benedetto D; Stifano G; Macrini M; Di Landro A; Di Luozzo M; Marchei M; Mariano EG; Cota L; Sergi D; Bezzeccheri A; Bonanni M; Baluci M; De Vico P; Romeo F
J Am Heart Assoc; 2020 Oct; 9(19):e017126. PubMed ID: 32901560
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on the efficacy and safety of fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction during the COVID-19 epidemic].
Wei F; Shuai XX; Chen ZJ; Cao GL; Wang L; Qiu T; Hu T; Wu L; Zhang Q; Huang HX; Zhang YW; Zhu L; Cheng X
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):472-476. PubMed ID: 32842256
[No Abstract] [Full Text] [Related]
8. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.
Xiang D; Xiang X; Zhang W; Yi S; Zhang J; Gu X; Xu Y; Huang K; Su X; Yu B; Wang Y; Fang W; Huo Y; Ge J
J Am Coll Cardiol; 2020 Sep; 76(11):1318-1324. PubMed ID: 32828614
[TBL] [Abstract][Full Text] [Related]
9. Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
Leng WX; Yang JG; Li XD; Jiang WY; Gao LJ; Wu Y; Yang YM; Yuan JQ; Yang WX; Qiao SB; Yang YJ
Int J Cardiol; 2021 Apr; 329():260-265. PubMed ID: 33307137
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
[TBL] [Abstract][Full Text] [Related]
11. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).
Mahmud E; Dauerman HL; Welt FGP; Messenger JC; Rao SV; Grines C; Mattu A; Kirtane AJ; Jauhar R; Meraj P; Rokos IC; Rumsfeld JS; Henry TD
Catheter Cardiovasc Interv; 2020 Aug; 96(2):336-345. PubMed ID: 32311816
[TBL] [Abstract][Full Text] [Related]
12. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
Kwok CS; Gale CP; Kinnaird T; Curzen N; Ludman P; Kontopantelis E; Wu J; Denwood T; Fazal N; Deanfield J; de Belder MA; Mamas M
Heart; 2020 Dec; 106(23):1805-1811. PubMed ID: 32868280
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.
Nan J; Meng S; Hu H; Jia R; Chen W; Li Q; Zhang T; Song K; Wang Y; Jin Z
Med Sci Monit; 2020 Sep; 26():e927061. PubMed ID: 32938901
[TBL] [Abstract][Full Text] [Related]
14. Management of ST elevation myocardial infarction (STEMI) with primary angioplasty in Covid 19 lockdown.
Kumar M; Tyagi N; Arora M
Indian Heart J; 2020; 72(4):325-326. PubMed ID: 32861396
[No Abstract] [Full Text] [Related]
15. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.
Elbadawi A; Mahtta D; Elgendy IY; Saad M; Krittanawong C; Hira RS; Omer M; Ogunbayo GO; Garratt K; Rao SV; Jneid H
JACC Cardiovasc Interv; 2020 Oct; 13(19):2312-2314. PubMed ID: 33032721
[No Abstract] [Full Text] [Related]
16. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
17. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Bainey KR; Bates ER; Armstrong PW
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
[No Abstract] [Full Text] [Related]
18. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
Lotfi AS; Capatina A; Kugelmass AD
Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
[No Abstract] [Full Text] [Related]
19. Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic.
Romaguera R; Ribera A; Güell-Viaplana F; Tomás-Querol C; Muñoz-Camacho JF; Agudelo V;
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):778-780. PubMed ID: 32565077
[No Abstract] [Full Text] [Related]
20. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
